We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
EverCommerce
EVCM
$1.93B
| $485K | ﹤0.01% |
65,176
-10,844
| -14% | -$82.9K |
|
|
DHC
2852
Diversified Healthcare Trust
DHC
$2.14B
| $482K | ﹤0.01% |
744,792
-361,942
| -33% | -$357K |
|
2853
First Bank
FRBA
$454M
| $482K | ﹤0.01% |
35,069
-6,896
| -16% | -$102K |
|
|
DZSI
2854
DELISTED
DZS Inc. Common Stock
DZSI
| $482K | ﹤0.01% |
38,011
-13,570
| -26% | -$173K |
|
2855
First Guaranty Bancshares
FGBI
$159M
| $475K | ﹤0.01% |
20,277
| – | – |
|
2856
NACCO Industries
NC
$320M
| $474K | ﹤0.01% |
12,468
| – | – |
|
2857
Lexicon Pharmaceuticals
LXRX
$1.1B
| $467K | ﹤0.01% |
244,650
-61,866
| -20% | -$132K |
|
|
AC
2858
DELISTED
Associated Capital Group
AC
| $465K | ﹤0.01% |
11,076
-977
| -8% | -$39.7K |
|
2859
Colony Bankcorp
CBAN
$467M
| $461K | ﹤0.01% |
36,393
-6,892
| -16% | -$92.9K |
|
|
VCSA
2860
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $461K | ﹤0.01% |
18,300
-25,109
| -58% | -$1.17M |
|
2861
Praxis Precision Medicines
PRAX
$10.1B
| $455K | ﹤0.01% |
12,771
-338
| -3% | -$10.5K |
|
|
AMRS
2862
DELISTED
Amyris Inc.
AMRS
| $454K | ﹤0.01% |
296,687
-324,440
| -52% | -$724K |
|
|
SOHU
2863
Sohu.com
SOHU
$357M
| $452K | ﹤0.01% |
33,000
-2,400
| -7% | -$35.5K |
|
2864
InnovAge Holding
INNV
$1.52B
| $451K | ﹤0.01% |
62,852
-12,407
| -16% | -$79.7K |
|
2865
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| – | – |
0
| – | – |
|
2866
Universal Technical Institute
UTI
$1.59B
| $448K | ﹤0.01% |
66,755
-1,885
| -3% | -$12.4K |
|
2867
Arena Group
AREN
$83.8M
| $446K | ﹤0.01% |
42,047
| – | – |
|
2868
Hippo Holdings
HIPO
$861M
| $446K | ﹤0.01% |
32,835
-7,354
| -18% | -$110K |
|
2869
Willdan Group
WLDN
$1.3B
| $443K | ﹤0.01% |
24,803
-14,244
| -36% | -$219K |
|
|
OMIC
2870
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $442K | ﹤0.01% |
7,334
-628
| -8% | -$42.1K |
|
2871
Samsara
IOT
$23.8B
| $441K | ﹤0.01% |
35,517
+5,875
| +20% | +$66.9K |
|
2872
Identive
INVE
$61.9M
| $436K | ﹤0.01% |
60,213
-3,599
| -6% | -$34.9K |
|
2873
HBT Financial
HBT
$1.32B
| $435K | ﹤0.01% |
22,238
| – | – |
|
|
ICVX
2874
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $435K | ﹤0.01% |
54,821
-16,555
| -23% | -$71.1K |
|
2875
Superior Group of Companies
SGC
$225M
| $432K | ﹤0.01% |
42,934
-3,910
| -8% | -$37.7K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.